Prostate cancer biomarkers detection using nanoparticles based electrochemical biosensors

被引:95
作者
Singh, Sima [1 ]
Gill, Atal A. S. [1 ]
Nlooto, Manimbulu [2 ]
Karpoormath, Rajshekhar [1 ]
机构
[1] UKZN, Coll Hlth Sci, Discipline Pharmaceut Sci, Westville Campus, ZA-4000 Durban, South Africa
[2] UKZN, Dept Pharm, Durban, South Africa
关键词
Prostate cancer (PCa); Electroanalysis; Biomarkers; Nanomaterials; Modified electrode; Electrochemical detection; POSITRON-EMISSION-TOMOGRAPHY; ROLLING CIRCLE AMPLIFICATION; SENSITIVE DETECTION; ANDROGEN RECEPTOR; MULTIPLE BIOMARKERS; EARLY-DIAGNOSIS; DRUG-DELIVERY; SERUM MARKER; ANTIGEN PSA; PROTEIN;
D O I
10.1016/j.bios.2019.03.065
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Prostate cancer (PCa) is the most prevalent cancer with a high mortality rate. The early and accurate detection of PCa can significantly reduce mortality and saves lives. Hence, the nanomaterials based electrochemical nanobiosensors for PCa biomarkers will be the excellent alternative for diagnosis, detection and management of disease condition. In this review, we present a concise summary of the latest attainment and advancement in the use of nanoparticles for the diagnosis of PCa biomarkers. This review highlighted the importance of applying specific biomarkers along with nanomaterials like gold, magnetic, carbon nanotubes, and many other materials for developing electrochemical nanobiosensors in PCa detection. In addition to a summary on PCa detection, we further ensure future perspectives in PCa biomarkers detection, sensitivity, simplicity, rapidity, accuracy, cost-effectiveness and succeeding optimizations of novel technologies for more feasibility. Finally, closing remarks and an outlook conclude the review.
引用
收藏
页码:213 / 221
页数:9
相关论文
共 125 条
[1]  
Adam BL, 2002, CANCER RES, V62, P3609
[2]  
[Anonymous], NANOTECHNOLOGY
[3]   Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer [J].
Armstrong, Andrew J. ;
Eisenberger, Mario A. ;
Halabi, Susan ;
Oudard, Stephane ;
Nanus, David M. ;
Petrylak, Daniel P. ;
Sartor, A. Oliver ;
Scher, Howard I. .
EUROPEAN UROLOGY, 2012, 61 (03) :549-559
[4]   Quantum dot - Aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on Bi-fluorescence resonance energy transfer [J].
Bagalkot, Vaishali ;
Zhang, Liangfang ;
Levy-Nissenbaum, Etgar ;
Jon, Sangyong ;
Kantoff, Philip W. ;
Langer, Robert ;
Farokhzad, Omid C. .
NANO LETTERS, 2007, 7 (10) :3065-3070
[5]   Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer [J].
Bahn, DK ;
Lee, F ;
Badalament, R ;
Kumar, A ;
Greski, J ;
Chernick, M .
UROLOGY, 2002, 60 (2A) :3-11
[6]   Prostate-specificy-antigen testing for early diagnosis of prostate cancer. [J].
Barry, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (18) :1373-1377
[7]   Ultrasensitive Electrochemical Sensors for PSA Detection: Related Surface Functionalization Strategies [J].
Blel, Nesrine ;
Fourati, Najla ;
Souiri, Mina ;
Zerrouki, Chouki ;
Omezzine, Asma ;
Bouslama, Ali ;
Othmanc, Ali .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (26) :2913-2925
[8]   Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer [J].
Blume-Jensen, Peter ;
Berman, David M. ;
Rimm, David L. ;
Shipitsin, Michail ;
Putzi, Mathew ;
Nifong, Thomas P. ;
Small, Clayton ;
Choudhury, Sibgat ;
Capela, Teresa ;
Coupal, Louis ;
Ernst, Christina ;
Hurley, Aeron ;
Kaprelyants, Alex ;
Chang, Hua ;
Giladi, Eldar ;
Nardone, Julie ;
Dunyak, James ;
Loda, Massimo ;
Klein, Eric A. ;
Magi-Galluzzi, Cristina ;
Latour, Mathieu ;
Epstein, Jonathan I. ;
Kantoff, Philip ;
Saad, Fred .
CLINICAL CANCER RESEARCH, 2015, 21 (11) :2591-2600
[9]   Serum antibodies to huntingtin interacting protein-1: A new blood test for prostate cancer [J].
Bradley, SV ;
Oravecz-Wilson, KI ;
Bougeard, G ;
Mizukami, I ;
Li, L ;
Munaco, AJ ;
Sreekumar, A ;
Corradetti, MN ;
Chinnaiyan, AM ;
Sanda, MG ;
Ross, TS .
CANCER RESEARCH, 2005, 65 (10) :4126-4133
[10]  
Bussemakers MJG, 1999, CANCER RES, V59, P5975